Taşkıran, H. Et Al. 2017. Development of Novel Compounds as Chemotherapeutic Drugs Targeting the p53-MDM2 and - MDM4 Interaction. Fifth International Congress of the Molecular Biology Association of Turkey, Istanbul, TURKEY , (İstanbul, Turkey), 188.

Taşkıran, H., Tolay, N., Gezen, M., Keskin , N., & Erman, M. B., (2017). Development of Novel Compounds as Chemotherapeutic Drugs Targeting the p53-MDM2 and - MDM4 Interaction . Fifth International Congress of the Molecular Biology Association of Turkey, Istanbul, TURKEY (pp.188). İstanbul, Turkey

Taşkıran, Hakan Et Al. "Development of Novel Compounds as Chemotherapeutic Drugs Targeting the p53-MDM2 and - MDM4 Interaction," Fifth International Congress of the Molecular Biology Association of Turkey, Istanbul, TURKEY, İstanbul, Turkey, 2017

Taşkıran, Hakan Et Al. "Development of Novel Compounds as Chemotherapeutic Drugs Targeting the p53-MDM2 and - MDM4 Interaction." Fifth International Congress of the Molecular Biology Association of Turkey, Istanbul, TURKEY , İstanbul, Turkey, pp.188, 2017

Taşkıran, H. Et Al. (2017) . "Development of Novel Compounds as Chemotherapeutic Drugs Targeting the p53-MDM2 and - MDM4 Interaction." Fifth International Congress of the Molecular Biology Association of Turkey, Istanbul, TURKEY , İstanbul, Turkey, p.188.

@conferencepaper{conferencepaper, author={Hakan Taşkıran Et Al. }, title={Development of Novel Compounds as Chemotherapeutic Drugs Targeting the p53-MDM2 and - MDM4 Interaction}, congress name={Fifth International Congress of the Molecular Biology Association of Turkey, Istanbul, TURKEY}, city={İstanbul}, country={Turkey}, year={2017}, pages={188} }